Table 3 Results of Cox regression analysis summarizing co-expressions of miR-182 with FGF2 and MMP-7, respectively
From: Stage and tissue-specific prognostic impact of miR-182 in NSCLC
Hazard ratio | 95% CI | P | |
|---|---|---|---|
Co-expression of miR-182/FGF2 | 0.021 | ||
High miR-182/low FGF2 | 1.00 | ||
High miR-182/high FGF2 and low miR-182/low FGF2 | 1.26 | 0.74-2.13 | 0.39 |
Low miR-182/high FGF2 | 1.92 | 1.14-3.24 | 0.015 |
Co-expression of miR-182/MMP-7 | 0.032 | ||
Low miR-182/low MMP-7 | 1.00 | ||
Low miR-182/high MMP-7 and high miR-182/low MMP-7 | 0.71 | 0.48-1.05 | 0.086 |
High miR-182/high MMP-7 | 0.49 | 0.27-0.87 | 0.015 |
Co-expression of miR-182/MMP-7, squamous cell carcinoma | 0.040 | ||
Low miR-182/low MMP-7 | 1.00 | ||
Low miR-182/high MMP-7 and high miR-182/low MMP-7 | 0.80 | 0.46-1.37 | 0.41 |
High miR-182/high MMP-7 | 0.26 | 0.090-0.74 | 0.012 |